TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
CMPX

Compass Therapeutics Inc.

Healthcare · Biotechnology

1.20$ -5.6% vs. previous close Closing price · As of: Sep 23, 2026

Filings

Filings

Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Compass Therapeutics Inc. (CMPX) with date, type and a link to the original document.

Filings CMPX
Date Type Filing Original
09/22/2026 Current report (8-K) Compass Therapeutics, Inc. (CMPX): Regulation FD Disclosure; Financial Statements and Exhibits View report ↗
08/07/2026 Ownership disclosure Form SC 13G filed with the SEC View document ↗
08/06/2026 Current report (8-K) Compass Therapeutics, Inc. (CMPX): Results of Operations and Financial Condition; Financial Statements and Exhibits View report ↗

Showing the 100 most recent filings of the selected type.

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?